Resultados de la búsqueda 411-420 of 18868 for Two-phase

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... two groups of patients ... Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... two groups of patients ... Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations.

  3. Oncología (médica) - Ensayos clínicos

    ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...

  4. Oncología (médica) - Ensayos clínicos

    ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...

  5. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    MC1733, Phase I Trial of Intratumoral ... The purpose of this study is to assess outcomes, satisfaction and aesthetics of two ... Ir a página 22 · Ir a ...

  6. Oncología (médica) - Ensayos clínicos

    Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients ... phase 2 dose (RP2D) and preferred schedule, and assess ...

  7. Oncología (médica) - Ensayos clínicos

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...

  8. Oncología (médica) - Ensayos clínicos

    Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients ... phase 2 dose (RP2D) and preferred schedule, and assess ...

  9. Dermatología - Ensayos clínicos

    ... Phase 2 dose (RP2D), as well as to evaluate preliminary effectiveness. Gemini Study to Evaluate the Integration of Cancer Genetic Testing into a Cancer ...

  10. Ensayos clínicos - Neurología

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...